Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Finds 4,300 Genes, Signs Expression Database Deal with UCB

Premium

GAITHERSBURG, Md.--Gene Logic said last week that with its Reads technology it has identified 2,513 genes associated with heart failure, renal disease, infertility, and other disorders, and 1,794 genes associated with mammalian toxicity. The 4,307 genes hold value as targets for new drugs or crop protection products or as markers to predict toxic effects of new compounds, the company claimed.

Earlier this month, UCB Research, a division of UCB Pharma, signed an agreement with Gene Logic for the development of a custom gene expression database for the discovery of new drugs for asthma and allergies. The companies will also collaborate to evaluate potential therapeutic targets resulting from the cooperation. Gene Logic will use its Reads technology and Affymetrix's GeneChip probe arrays to identify genes that are more or less active, or differentially expressed, in people with asthma and allergies than in healthy individuals.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.